Global Equity Flows Chasing Momentum Over Value Analyst Anurag Singh Observes Life Time Group LTH Positioned as a Potential Leader in the Health and Fitness Sector Mercury Valuation Soars to 52 Billion in Latest Funding Round Marking 49 Increase in 14 Months Amid Conflict Israeli and Arab Entrepreneurs Forge Economic Partnerships Billionaire Investor John Doerr Says AI Revolution Remains Underhyped Despite Years of Frenzy Russia Warns of Systematic Kyiv Strikes Escalating Geopolitical Risk for Global Markets DORM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment General Dynamics Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction FULTP Q1 2026 Earnings Preferred Stock Reports EPS Beat Amid Steady Performance CrossAmerica Partners LP CAPL Q1 2026 Earnings Strong Earnings Surprise Offsets Missing Revenue Data CETY Q4 2024 Earnings Net Loss of 002 Per Share as Clean Energy Firm Navigates Growth Phase DEFSEC Technologies Inc DFSC Q2 2024 Earnings EPS Misses Estimates Stock Rises on Strategic Outlook Adams Natural Resources Fund PEO Holds Steady Near Support as Energy Sector Stabilizes Agriculture Natural Solutions Acquisition Warrant ANSCW Holds Flat at 023 Amid Low Volume Gladstone Investment Notes GAING Hold Steady at 2532 as Market Awaits Rate Clarity IsoEnergy Ltd ISOU Rallies Over 3 as Uranium Sector Sees Renewed Interest CPS Technologies CPSH Surges 127 on High Volume Testing Key Resistance at 552 Streaming Platforms Gear Up for Weekend Content Drop Netflix Hulu Prime Video Apple TV and More Unveil New Releases ixigo Partners with Uber and redBus to Integrate Cab and Bus Booking into Train App TikTok and YouTube Face Scrutiny Over Child Safety Standards by UK Regulator Ofcom Standard Chartered CEO Apologizes for Lower Value Human Capital Remark Overlooked Dividend King Industrial Sectors Hidden Gem May Offer LongTerm Value Reddit Shares Tumble as Meta Launches Standalone Facebook Groups App Forum Unifirst Q1 2026 Earnings EPS Beats Estimates by 212 Modest Stock Uptick KalVista Pharmaceuticals KALV Holds Steady Near Support After Modest Gain